MAPT and Alzheimer disease: Future research could integrate PET imaging (e.g., tau distribution) and single-cell sequencing to further elucidate the molecular and cellular mechanisms underlying DFC abnormalities, promoting its application in early AD diagnosis and treatment monitoring.